EVAX Annual CFF
$10.69 M
+$2.84 M+36.14%
31 December 2023
Summary:
As of January 23, 2025, EVAX annual cash flow from financing activities is $10.69 million, with the most recent change of +$2.84 million (+36.14%) on December 31, 2023. During the last 3 years, it has risen by +$1.87 million (+21.25%). EVAX annual CFF is now -78.53% below its all-time high of $49.80 million, reached on December 31, 2021.EVAX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVAX Quarterly CFF
N/A
01 September 2024
Summary:
EVAX quarterly cash flow from financing activities is not available.EVAX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVAX TTM CFF
N/A
01 September 2024
Summary:
EVAX TTM cash flow from financing activities is not available.EVAX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVAX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.1% | - | - |
| 3 y3 years | +21.3% | - | - |
| 5 y5 years | +18.4% | - | - |
EVAX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -78.5% | +36.1% | ||||
| 5 y | 5-year | -78.5% | +36.1% | ||||
| alltime | all time | -78.5% | +36.1% |
Evaxion Biotech A/S Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $10.69 M(+36.1%) | - | - |
| Dec 2022 | $7.85 M(-84.2%) | - | - |
| June 2022 | - | -$300.00 K(-103.9%) | $32.03 M(-0.8%) |
| Mar 2022 | - | $7.74 M(-68.6%) | $32.29 M(-35.2%) |
| Dec 2021 | $49.80 M | $24.65 M(<-9900.0%) | $49.80 M(+80.9%) |
| Sept 2021 | - | -$65.00 K(+85.7%) | $27.53 M(-19.2%) |
| June 2021 | - | -$35.00 K(-100.1%) | $34.07 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $25.25 M(+963.7%) | $34.09 M(+286.6%) |
| Dec 2020 | $8.82 M(-7.3%) | $2.37 M(-63.4%) | $8.82 M(+36.8%) |
| Sept 2020 | - | $6.48 M(<-9900.0%) | $6.44 M(<-9900.0%) |
| June 2020 | - | -$18.00 K(0.0%) | -$36.00 K(+100.0%) |
| Mar 2020 | - | -$18.00 K | -$18.00 K |
| Dec 2019 | $9.51 M(+5.3%) | - | - |
| Dec 2018 | $9.03 M | - | - |
FAQ
- What is Evaxion Biotech A/S annual cash flow from financing activities?
- What is the all time high annual CFF for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S annual CFF year-on-year change?
- What is the all time high quarterly CFF for Evaxion Biotech A/S?
- What is the all time high TTM CFF for Evaxion Biotech A/S?
What is Evaxion Biotech A/S annual cash flow from financing activities?
The current annual CFF of EVAX is $10.69 M
What is the all time high annual CFF for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high annual cash flow from financing activities is $49.80 M
What is Evaxion Biotech A/S annual CFF year-on-year change?
Over the past year, EVAX annual cash flow from financing activities has changed by +$2.84 M (+36.14%)
What is the all time high quarterly CFF for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high quarterly cash flow from financing activities is $25.25 M
What is the all time high TTM CFF for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high TTM cash flow from financing activities is $49.80 M